LearnGlossaryMarketStocksSuperinvestorsSign in

BBTX

Bambusa Therapeutics, Inc.

Verdict

We can't put a fair value on BBTX right now. We haven't analysed this company yet.

Follow BBTX

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Oct 29, 2026: 2 open-market purchases worth $12.0M and 26 other filings (stock awards, tax withholding and similar). Why purchases matter

Purchases

Jeggle Helmut Wolfgang

director · 2026-11-02

Bought

$6.0M

Salvia Investment GmbH

Owns 10%+ · 2026-11-02

Bought

$6.0M

Other filings

MiNeng, Inc.

Owns 10%+ · 2026-11-02

C-Conversion

15,789 shares

MiNeng, Inc.

Owns 10%+ · 2026-11-02

C-Conversion

94,050 shares

MiNeng, Inc.

Owns 10%+ · 2026-11-02

C-Conversion

37,399 shares

MiNeng, Inc.

Owns 10%+ · 2026-11-02

C-Conversion

1,753 shares

MiNeng, Inc.

Owns 10%+ · 2026-11-02

C-Conversion

10,450 shares

Questions about BBTX

Are insiders buying BBTX?

Since Oct 29, 2026: 2 open-market purchases worth $12.0M and 26 other filings (stock awards, tax withholding and similar).

How can I check BBTX's value myself?

Use the free Sticker Price calculator, already filled with BBTX's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Nov 3, 2026. How the Payback Price works